Daily Tadalafil in Diabetic ED Patients

Launched by SOUTH VALLEY UNIVERSITY · May 7, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how a medication called tadalafil, taken daily at a dose of 5 mg, affects men with erectile dysfunction (ED) related to type 2 diabetes. The researchers want to see if this treatment can change certain levels in the body that are linked to blood vessel health. They will compare the results of men taking tadalafil with those of healthy men who do not have diabetes or erectile dysfunction.

To be part of this study, participants need to be men aged between 30 and 60 years who have diabetes and are experiencing erectile dysfunction. They should not have any serious health issues like high blood pressure or major illnesses, and they should not have had significant injuries or surgeries in the pelvic area. The trial is not yet recruiting participants, but once it starts, those who join can expect to take the medication daily and undergo health assessments to monitor how they are responding to the treatment.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Male patients aged between 30 and 60 yearsز Diagnosed with diabetes mellitus Suffering from erectile dysfunction No history of hypertension or other systemic diseases
• Exclusion Criteria:
• • History of pelvic trauma or major pelvic surgery Pacientes con hipogonadismo o hiperprolactinemia Chronic liver disease or cardiovascular disorders Chronic use of central nervous system drugs, anti-androgenic drugs, or Tramadol Smokers Non-vasculogenic erectile dysfunction Known allergy to tadalafil